Expression of CXCL12 and its receptor CXCR4 correlates with lymph node metastasis in submucosal esophageal cancer-Reference-Cited by-同舟云学术

Expression of CXCL12 and its receptor CXCR4 correlates with lymph node metastasis in submucosal esophageal cancer

Published:2008 Issue:5 Volume:97 Page:433-438
ISSN:0022-4790
Container-title:Journal of Surgical Oncology
language:en
Short-container-title:J. Surg. Oncol.

Author:

Sasaki Ken,Natsugoe Shoji,Ishigami Sumiya,Matsumoto Masataka,Okumura Hiroshi,Setoyama Tetsuro,Uchikado Yasuto,Kita Yoshiaki,Tamotsu Kiyokazu,Sakurai Toshihide,Owaki Tetsuhiro,Aikou Takashi

Publisher

Wiley

Subject

Oncology,General Medicine,Surgery

Reference34 articles.

1. Clinical significance of occult micrometastasis in lymph nodes from patients with early gastric cancer who died of recurrence

2. Identification of occult micrometastases in pericolic lymph nodes of Dukes' B colorectal cancer patients using monoclonal antibodies against cytokeratin and CC49. Correlation with long-term survival

3. Restaging of colorectal cancer based on the identification of lymph node micrometastases through immunoperoxidase staining of CEA and cytokeratins

4. Prognostic significance of occult lymph node metastases in node-negative breast cancer

5. Overexpression of Vascular Endothelial Growth Factor-C Correlates With Lymph Node Micrometastasis in Submucosal Esophageal Cancer

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The CXCR4 might be a potential biomarker for esophageal squamous cell carcinoma: A meta-analysis;Medicine;2024-04-05

2. Enhanced CXCL12/CXCR4 signaling increases tumor progression in radiation‑resistant pancreatic cancer;Oncology Reports;2022-02-03

3. CXCL12-CXCR4 AXIS: ITS ROLE AND THE DRUG INHIBITORS ON EACH TYPE OF CANCERS;WORLD CANCER RES J;2022

4. The CXCL12-CXCR4 Signaling Axis Plays a Key Role in Cancer Metastasis and is a Potential Target for Developing Novel Therapeutics against Metastatic Cancer;Current Medicinal Chemistry;2020-10-08

5. Tandem post-synthetic modification of a zeolitic imidazolate framework for CXCR4-overexpressed esophageal squamous cell cancer imaging and therapy;Nanoscale;2020